Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes.

Research Article

Br Med J 1979; 2 doi: https://doi.org/10.1136/bmj.2.6200.1257 (Published 17 November 1979) Cite this as: Br Med J 1979;2:1257

Cited by...

Higher risk of severe hypoglycemia in children and adolescents with a rapid loss of C-peptide during the first 6 years after type 1 diabetes diagnosis
- Abstract
- Fulltext
- PDF
Better HbA1c during the first years after diagnosis of type 1 diabetes is associated with residual C peptide 10 years later
- Abstract
- Fulltext
- PDF
Frequent Monitoring of C-peptide Levels in Newly Diagnosed Type 1 Subjects Using Dried Blood Spots Collected at Home
- Abstract
- Fulltext
- PDF
Increased Interleukin-35 Levels in Patients With Type 1 Diabetes With Remaining C-Peptide
- Abstract
- Fulltext
- PDF
Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes: Two-Year Results From the Randomized, Placebo-Controlled Protege Trial
- Abstract
- Fulltext
- PDF
Antidiabetic Actions of Endogenous and Exogenous GLP-1 in Type 1 Diabetic Patients With and Without Residual {beta}-Cell Function
- Abstract
- Fulltext
- PDF
Age at Onset and the Risk of Proliferative Retinopathy in Type 1 Diabetes
- Abstract
- Fulltext
- PDF
Preservation of {beta}-Cell Function in Autoantibody-Positive Youth With Diabetes
- Abstract
- Fulltext
- PDF
Medial Artery Calcification: A Neglected Harbinger of Cardiovascular Complications in Non Insulin-Dependent Diabetes Mellitus
- Abstract
- Fulltext
- PDF